ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

DOD Bill Passes Senate; Prostate Cancer Gets $75 Mil.; Breast Cancer Recieves $175 Mil.

June 25, 1999

NCI Programs: Seven Win Awards For Cancer Genetics Network, Informatics

July 31, 1998

HEW Approves New Cancer Clinical Education Grants, Without Trainee Stipends ; $4 Million Available In ’75

April 26, 1974

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

Program Announcements. RAPID Program Date Change.

June 29, 2001

In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor

May 10, 1996